$BRVO
Bravo Multinational Inc.
CIK:0001444839|SEC Filings
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Expenses | ||||
| General and Administrative | $ 4,874 | $ 4,555 | $ 7,097 | $ 6,475 |
| Professional Fees | 32,270 | 20,730 | 41,162 | 46,080 |
| Board of Director Fees | 43,750 | 43,750 | 190,400 | 87,500 |
| Total Expenses | 80,894 | 69,035 | 238,659 | 140,055 |
| Loss Before Other Income | 80,894 | 69,035 | 238,659 | 140,055 |
| Legal Settlement | 28,588 | |||
| Loss Before Income Taxes | 80,894 | 69,035 | 210,071 | 140,055 |
| Income Taxes | ||||
| Net Loss for the Period | $ 80,894 | $ 69,035 | $ 210,071 | $ 140,055 |
| Weighted Average Number of Common Shares - Basic | 48,690,693 | 47,641,010 | 48,162,953 | 47,641,010 |
| Weighted Average Number of Common Shares - Diluted | 48,690,693 | 47,641,010 | 48,162,953 | 47,641,010 |
| Net Loss for the Period Per Common Shares - Basic | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.00) |
| Net Loss for the Period Per Common Shares - Diluted | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.00) |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Cash Flows from Operating Activities | ||
| Net Loss for the Period | $ (210,071) | $ (140,055) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Board of Director Fees Paid with Common Stock | 92,900 | |
| Changes in Assets and Liabilities: | ||
| Accounts Payable and Accrued Expenses | 17,129 | 2,285 |
| Accrued Board of Directors Fees | 79,500 | 85,650 |
| Net Cash Flows Used In Operating Activities | (20,542) | (52,120) |
| Cash Flows from Investing Activities | ||
| Cash Flows from Financing Activities | ||
| Due to Related Parties, Net | 22,750 | 52,430 |
| Net Cash Flows Provided by Financing Activities | 22,750 | 52,430 |
| Net Change in Cash and Cash Equivalents | 2,208 | 310 |
| Cash and Cash Equivalents - Beginning of Period | 111 | 288 |
| Cash and Cash Equivalents - End of Period | 2,319 | 598 |
| Cash Paid During the Period for: | ||
| Interest | ||
| Income Taxes | ||
CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Current Assets | ||
| Cash and Cash Equivalents | $ 2,319 | $ 111 |
| Total Current Assets | 2,319 | 111 |
| Total Assets | 2,319 | 111 |
| Liabilities | ||
| Accounts Payable and Accrued Expenses | 148,122 | 130,995 |
| Due to Related Parties | 392,053 | 369,303 |
| Accrued Board of Directors Fees | 634,900 | 555,400 |
| Total Liabilities | 1,175,075 | 1,055,698 |
| Stockholders' Deficit | ||
| Common Stock - $0.0001 Par; 1,000,000,000 Shares Authorized, 50,419,582 and 47,641,010 Issued and Outstanding, Respectively | 5,041 | 4,763 |
| Additional Paid-In-Capital | 95,466,921 | 95,374,299 |
| Accumulated Deficit | (96,644,718) | (96,434,649) |
| Total Stockholders' Deficit | (1,172,756) | (1,055,587) |
| Total Liabilities and Stockholders' Deficit | 2,319 | 111 |
| Series A Preferred Stock [Member] | ||
| Stockholders' Deficit | ||
| Preferred stock value |